NCIC Clinical Trials Group

Brain Gastro-Intestinal Gynecologic Hematologic Lung Sarcoma
Breast Genito-Urinary Head & Neck IND Melanoma Symptom Control
 

Search utility

Permanent Trial Closure

january 2012

Permanent Trial Closure Notice for Phase I/II/III NCIC CTG Led Studies

September 2011

Permanent Trial Closure Notice for Phase I/II/III Intergroup Led Studies - CL1

January 2011

Permanent Trial Closure Notice for Phase I/II/III NCIC CTG Led Studies

Permanent Trial Closure Notice for Phase I/II/III Intergroup Led Studies

January 2010

Intergroup Led Permanent Closure Letter

BR10 Accomplishments

December 2009

Permanent Trial Closure Notice for Phase I/II/III NCIC CTG Led Studies

Further to Notice of MA.15 Permanent Closure

June 2009

Additional Trials Closed 09Jun12 -- MA.10, MA.5, and CO.3

Accomplishments of MA.5

May 2009

Final Closure Notice for Phase I/II/III Intergroup Led Studies - Part 3

February 2009

Final Closure Notice for Phase I/II/III NCIC CTG Led Studies - Part 2 + Addendum

Follow-Up Requirements IND Studies Cover Letter

Follow-Up Requirements IND Studies Appendix A

Follow-Up Requirements IND Studies Appendix B

December 2008

Final Closure Notice for Phase I/II/III NCIC CTG Led Studies - Part 1

Use this to link back to CTG home only

If you have any questions, comments or suggestions, please contact our